Company Overview

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

  • Name

    Thermo Fisher Scientific Inc.

  • CEO

    Mr. Marc N. Casper

  • Website

    www.thermofisher.com

  • Sector

    Life Sciences Tools and Services

  • Year Founded

    1956

Profile

  • Market Cap

    $234.6B

  • EV

    $261.31B

  • Shares Out

    382M

  • Revenue

    $42.35B

  • Employees

    122,000

Margins

  • Gross

    40.69%

  • EBITDA

    25.42%

  • Operating

    17.58%

  • Pre-Tax

    16.01%

  • Net

    14.69%

  • FCF

    18.8%

Returns (5Yr Avg)

  • ROA

    8.2%

  • ROTA

    29.03%

  • ROE

    16.81%

  • ROCE

    11.71%

  • ROIC

    10.85%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $642.56

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $8,823M

  • Net Debt

    $26.6B

  • Debt/Equity

    0.75

  • EBIT/Interest

    5.1

Growth (CAGR)

  • Rev 3Yr

    3.45%

  • Rev 5Yr

    11.23%

  • Rev 10Yr

    11.02%

  • Dil EPS 3Yr

    -9.27%

  • Dil EPS 5Yr

    12.99%

  • Dil EPS 10Yr

    15.41%

  • Rev Fwd 2Yr

    3.19%

  • EBITDA Fwd 2Yr

    3.79%

  • EPS Fwd 2Yr

    5.47%

  • EPS LT Growth Est

    9.45%

Dividends

  • Yield

  • Payout

    9.14%

  • DPS

    $1.48

  • DPS Growth 3Yr

    15.52%

  • DPS Growth 5Yr

    15.5%

  • DPS Growth 10Yr

    9.45%

  • DPS Growth Fwd 2Yr

    6.04%

NYSE:TMO